|
|
Volumn 13, Issue 7, 2002, Pages 1029-1035
|
|
Phase II trial of thalidomide in renal-cell carcinoma
|
|
Author keywords
Anti angiogenic drugs; Renal cancer; Thalidomide
|
|
Indexed keywords
BASIC FIBROBLAST GROWTH FACTOR;
CYTOKINE;
INTERLEUKIN 12;
THALIDOMIDE;
TUMOR NECROSIS FACTOR ALPHA;
VASCULOTROPIN;
ANGIOGENESIS INHIBITOR;
TUMOR MARKER;
ADULT;
AGED;
ARTICLE;
BLOOD LEVEL;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEATH;
DOPPLER ECHOGRAPHY;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG RESPONSE;
DRUG TOLERABILITY;
ELECTROMYOGRAPHY;
FATIGUE;
FEMALE;
HUMAN;
KIDNEY CARCINOMA;
LETHARGY;
LUNG EMBOLISM;
MALE;
METASTASIS;
NAUSEA;
NEUROPATHY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RASH;
THROMBOEMBOLISM;
TUMOR VASCULARIZATION;
AGE;
CANCER STAGING;
COMPARATIVE STUDY;
COMPUTER ASSISTED TOMOGRAPHY;
CONFIDENCE INTERVAL;
DISEASE FREE SURVIVAL;
DOPPLER FLOWMETRY;
DOSE RESPONSE;
DRUG ADMINISTRATION;
FOLLOW UP;
KIDNEY TUMOR;
METHODOLOGY;
MIDDLE AGED;
MONITORING;
MORTALITY;
NEEDLE BIOPSY;
PATHOLOGY;
RISK;
SEX DIFFERENCE;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADULT;
AGE FACTORS;
AGED;
ANGIOGENESIS INHIBITORS;
BIOPSY, NEEDLE;
CARCINOMA, RENAL CELL;
COMPARATIVE STUDY;
CONFIDENCE INTERVALS;
CYTOKINES;
DISEASE-FREE SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
HUMAN;
KIDNEY NEOPLASMS;
MALE;
MIDDLE AGE;
MONITORING, PHYSIOLOGIC;
NEOPLASM STAGING;
ODDS RATIO;
SEX FACTORS;
SURVIVAL RATE;
THALIDOMIDE;
TOMOGRAPHY, X-RAY COMPUTED;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
ULTRASONOGRAPHY, DOPPLER;
HUMANS;
MIDDLE AGED;
|
|
EID: 0035990828
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/annonc/mdf213 Document Type: Article |
|
Times cited : (107)
|
|
References (28)
|
